2017
JW Xue, ZK Zhao, L Zhang, LJ Xue, SY Shen, YJ Wen, ZY Wei, L Wang, LY Kong, HB Sun, QN Ping, R Mo*, C Zhang*. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nature Nanotechnology, 2017, 12(7): 692-700. (IF 38.986)
X Feng, W Yu, X Li, F Zhou, W Zhang, Q Shen, J Li, C Zhang*, P Shen*. Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation. Biochemical Pharmacology, 2017, 136:136-149. (IF 4.75)
2017 Apigenin, a modulator of PPARc, attenuates HFD-induced NAFLD.pdf
T Cui, JJ Liang, H Chen, DD Geng, L Jiao, JY Yang, H Qian, C Zhang*, Y Ding*. Performance of Doxorubicin-Conjugated Gold Nanoparticles: Regulation of Drug Location. ACS Applied Materials & Interfaces, 2017, 9(10): 8569-8580. (IF: 7.504)
2017 Performance of Doxorubicin-Conjugated Gold.pdf
B Wang, MX Hao, C Zhang*. Design, synthesis and biological evaluation of nonsecosteroidal vitamin D3 receptor ligands as anti-tumor agents. Bioorganic & Medicinal Chemistry Letters, 2017, 27: 1428-1436. (IF: 2.454)
2017 Design, synthesis and biological evaluation of nonsecosteroidal vitamin.pdf
XY Chen, YD Zhang, CM Tang, CL Tian, Q Sun, ZG Su, LJ Xue, YF Yin, CY Ju*, C Zhang*. Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis. International Journal of Pharmaceutics, 2017, 529(1-2): 102-115. (IF: 3.649)
2017 Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive.pdf